Though research continues to show mixed findings, several more studies have shown positive for XMRV in CFS, including two in Europe (Spain and Norway). This suggests that the key is proper testing technology.
This continues to help increase awareness and acceptance of CFS. Though current therapies can be very helpful, there is always room for improvement, and we continue to explore new therapies that are promising. The push now is to research different antiviral therapies and combinations in people with CFS.
More interesting news? Professor Montoya, who did the original research using Valcyte for CFS, reported on a placebo-controlled study showing improvement in a subset of CFS patients suspected of having HHV 6 end EBV viral infections. This study will be submitted for publication later this month.
Things get more and more optimistic!
For more information on addressing viral infections in CFS (including using the antiviral Valcyte), see my article Addressing Hidden Viral Infections in CFS/FMS Can Sometimes be a Cure (reprinted from my book From Fatigued to Fantastic!).